PPARalpha activators may be good candidates as antiaging agents

Area of Science:

• Gerontology
• Metabolic Science
• Immunology

Background:

• Aging is linked to metabolic dysfunction, including altered fat distribution, obesity, and insulin resistance.
• Age-related immune system decline contributes to increased infections, poor vaccine response, and chronic diseases.
• Leptin, a key metabolic regulator, shows resistance with aging, exacerbating obesity and insulin resistance.

Purpose of the Study:

• To investigate the role of leptin resistance in age-related metabolic decline.
• To explore the potential of Peroxisome proliferator-activated receptor (PPAR)-alpha activators in counteracting aging-associated metabolic and immune dysfunction.

Main Methods:

• Examined the relationship between aging, leptin levels, and metabolic parameters like obesity and insulin resistance.
• Investigated the effects of PPAR-alpha activation on cellular redox balance, inflammation, and immune function in the context of aging.

Main Results:

• Increased plasma leptin levels in aging suggest leptin resistance, correlating with abdominal obesity and insulin resistance.
• PPAR-alpha, upregulated by hyperleptinemia, mediates lipid metabolism and influences glucose and energy homeostasis.
• PPAR-alpha activators improved cellular redox balance, reduced lipid peroxidation, eliminated NF-kappaB activity, and decreased inflammatory cytokine production, thereby improving aging immunity.

Conclusions:

• Leptin resistance is a significant factor in the metabolic decline associated with aging.
• PPAR-alpha activation offers a promising therapeutic strategy to mitigate age-related metabolic dysfunction and immune senescence.